Continuous glucose monitoring improved glucose control in adults but not in young adults or children with type 1 diabetes
R W Beck
Dr R W Beck, Jaeb Center for Health Research, Tampa, FL, USA; rbeck@jaeb.org
QUESTION
Does continuous glucose monitoring (CGM) improve glucose control in adults and children with type 1 diabetes?
METHODS
Design:
randomised controlled trial. ClinicalTrials.gov NCT00406133.
Allocation:
{concealed}.*
Blinding:
unblinded.
Follow-up period:
26 weeks.
Setting:
10 centres in the USA.
Patients:
322 adults and children ⩾8 years of age who had type 1 diabetes for ⩾1 year and glycated haemoglobin (HbA1c) concentrations of 7–10%, received intensive insulin therapy through an insulin pump or ⩾3 daily injections, had not recently used CGM at home, and successfully completed a 1-week run-in phase. Patients were stratified into 3 age groups: ⩾25 years (n = 98), 15–24 years (n = 110), and 8–14 years (n = 114).
Intervention:
CGM using a subcutaneous sensor …
